Recombinant multi-species LYPLA2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LYPLA2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. There are alternatively spliced transcript variants described for this gene but the full length nature is not known yet. [provided by RefSeq, Jul 2008]
The Alternative Names of target: APT-2,APT2,Acyl-protein thioesterase 2,DJ886K2.4,LYPLA2,Lypla2,LysoII,LysoPLA II),Lysophospholipase II (LPL-II,Palmitoyl-protein hydrolase

Target products collectionGo to LYPLA2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP4112-Ag-1/ GM-Tg-hg-IP4112-Ag-2 Human LYPLA2 protein Human
GM-Tg-rg-IP4112-Ag-1/ GM-Tg-rg-IP4112-Ag-2 Rat LYPLA2 protein Rat
GM-Tg-mg-IP4112-Ag-1/ GM-Tg-mg-IP4112-Ag-2 Mouse LYPLA2 protein Mouse
GM-Tg-cynog-IP4112-Ag-1/ GM-Tg-cynog-IP4112-Ag-2 Cynomolgus/Rhesus macaque LYPLA2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP4112-Ag-1/ GM-Tg-felg-IP4112-Ag-2 Feline LYPLA2 protein Feline
GM-Tg-cang-IP4112-Ag-1/ GM-Tg-cang-IP4112-Ag-2 Canine LYPLA2 protein Canine
GM-Tg-bovg-IP4112-Ag-1/ GM-Tg-bovg-IP4112-Ag-2 Bovine LYPLA2 protein Bovine
GM-Tg-equg-IP4112-Ag-1/ GM-Tg-equg-IP4112-Ag-2 Equine LYPLA2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP4112-Ag-1/ GM-Tg-hg-IP4112-Ag-2; GM-Tg-rg-IP4112-Ag-1/ GM-Tg-rg-IP4112-Ag-2;
GM-Tg-mg-IP4112-Ag-1/ GM-Tg-mg-IP4112-Ag-2; GM-Tg-cynog-IP4112-Ag-1/ GM-Tg-cynog-IP4112-Ag-2;
GM-Tg-felg-IP4112-Ag-1/ GM-Tg-felg-IP4112-Ag-2; GM-Tg-cang-IP4112-Ag-1/ GM-Tg-cang-IP4112-Ag-2;
GM-Tg-bovg-IP4112-Ag-1/ GM-Tg-bovg-IP4112-Ag-2; GM-Tg-equg-IP4112-Ag-1/ GM-Tg-equg-IP4112-Ag-2
Products Name LYPLA2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name LYPLA2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LYPLA2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.